Optimizing the Announcement of Advanced or Metastatic Prostate Cancer Using Animated Videos (CartDiag PROSTATE)
NCT06117696 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2023-11-07
Summary
In hospitals, the standard prostate cancer announcement system is based on oral and written information. To improve this system, we have developed animated videos that retrace the patient's care path.
This is an exploratory, controlled, before-and-after, multicenter study designed to assess the effect of a standard announcement system reinforced by animated videos on patients' level of understanding of prostate cancer diagnosis and treatment. Patients' perception of information will be assessed using the EORTC QLQ-INFO25 questionnaire.
Conditions
Interventions
- OTHER
-
Animated video
delivery of written and oral information, supported by animated videos.
Sponsors & Collaborators
-
Direction Centrale du Service de Santé des Armées
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-31
- Primary Completion
- 2024-10-31
- Completion
- 2024-10-31
Countries
- France
- Guadeloupe
Study Locations
More Related Trials
-
F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer
NCT01981707 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed
NCT04462926 ·Status: UNKNOWN ·Phase: NA
-
Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study
NCT01797692 ·Status: COMPLETED ·Phase: NA
-
Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy
NCT04048252 ·Status: COMPLETED
-
Functional Medical Imaging Quantization in Prostate Cancer
NCT03376360 ·Status: COMPLETED
-
Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers
NCT03585114 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer
NCT04702633 ·Status: COMPLETED
-
PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) Progressing
NCT06460454 ·Status: COMPLETED
-
Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma
NCT00230386 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer
NCT05477823 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
NCT03976843 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy
NCT05896371 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Threedimensional Multiparametric Ultrasound for Prostate Cancer Detection
NCT04605276 ·Status: COMPLETED
-
Development of Artificial Intelligence Models for Segmentation and Characterization of Prostate Cancer: a Single-center Retrospective Observational Study.
NCT06168864 ·Status: COMPLETED
-
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
NCT05764005 ·Status: COMPLETED ·Phase: NA
-
Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer
NCT02722525 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients
NCT03164837 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
NCT03739684 ·Status: COMPLETED ·Phase: PHASE3
-
PSMA-PET Imaging in Patients With Metastatic Prostate Cancer: Institutional Evaluation of Detection Yield Performance and Reproducibility
NCT03486886 ·Status: COMPLETED ·Phase: NA
-
A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging
NCT03445559 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PSMA-Guided Ablation of the Prostate
NCT06003556 ·Status: RECRUITING ·Phase: PHASE2
-
Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate Cancer
NCT03623425 ·Status: UNKNOWN ·Phase: PHASE3
-
All-in-One Prostate Cancer Staging with MRI
NCT06071195 ·Status: RECRUITING
-
Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients
NCT03344822 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Assessment of Prostate MRI Before Prostate Biopsies
NCT02485379 ·Status: COMPLETED ·Phase: NA